secwatch.observer — SEC 8-K summary
======================================

Issuer:     LianBio (LIANY)
CIK:        0001831283
Form:       8-K
Filed at:   2023-12-20T23:59:59+00:00
Accession:  0001831283-23-000141
Event type: leadership
Sentiment:  neutral
Materiality: 0.60
Item codes: 5.02, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

LianBio CFO Yi Larson resigns; Ehong Gu named interim CFO
---------------------------------------------------------

- Yi Larson resigned as CFO effective December 19, 2023, to pursue other opportunities.
- Separation agreement provides severance of $2,430,124 paid in installments and lump sum.
- Ehong Gu, VP Head of Global Finance, appointed interim CFO as principal financial officer.
- Gu has held senior finance roles at CStone, BeiGene, and Celgene; no compensation terms set yet.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1831283/000183128323000141/0001831283-23-000141-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1831283/000183128323000141/lian-20231219.htm
  HTML page:      https://secwatch.observer/filing/0001831283-23-000141

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer